Kimberly Shea, PhDAssistant Professor, Epidemiology
BiographyKimberly Shea, PhD, MPH, is Assistant Professor in the Department of Epidemiology at Boston University. Before joining the Department of Epidemiology, Dr. Shea served a Peace Corps Volunteer in Kenya, and conducted laboratory-based HIV vaccine research. Dr. Shea’s research interests include the epidemiology of infectious diseases, especially the epidemiology of vaccine-preventable diseases and the post-licensure effectiveness of vaccination. She is currently engaged in evaluating changes in pneumococcal and meningococcal serotype distributions following the introduction of the childhood pneumococcal vaccine, the capacity of specific pneumococcal serotypes to cause disease, and several pneumococcal and meningococcal disease surveillance activities shared by the Massachusetts Department of Public Health and Boston University. In addition, Dr. Shea is currently overseeing a collaborative project between Boston University and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the Centers for Disease Control and Prevention to calculate the rate of reactivation tuberculosis in the US. Dr. Shea has been involved in teaching several classes at the Boston University School of Public Health including the Introduction to Epidemiology, Intermediate Epidemiology, Infectious Disease Epidemiology and the Epidemiology of Vaccine-Preventable Diseases.
- Boston Medical Center
- Boston University School of Public Health, PhD
- Boston University School of Public Health, MPH
- Published on 5/13/2014
Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. Clin Infect Dis. 2014 Sep 1; 59(5):615-23.
- Published on 10/18/2013
Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014 Jan 15; 179(2):216-25.
- Published on 4/26/2013
Hsu KK, Rifas-Shiman SL, Shea KM, Kleinman KP, Lee GM, Lakoma M, Pelton SI, Finkelstein JA, Huang SS. Do community-level predictors of pneumococcal carriage continue to play a role in the conjugate vaccine era? Epidemiol Infect. 2014 Feb; 142(2):379-87.
- Published on 3/28/2013
Horsburgh CR, Shea KM, Phillips P, Lavalley M. Randomized clinical trials to identify optimal antibiotic treatment duration. Trials. 2013; 14:88.
- Published on 1/25/2013
Hak E, Shea KM, Jick SS. Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD. Vaccine. 2013 Mar 15; 31(12):1590-6.
- Published on 8/24/2011
Shea KM, Weycker D, Stevenson AE, Strutton DR, Pelton SI. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US. Vaccine. 2011 Oct 19; 29(45):8042-8.
- Published on 3/1/2011
Hsu KK, Shea KM, Stevenson AE, Pelton SI. Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era. Pediatr Infect Dis J. 2011 Mar; 30(3):251-3.
- Published on 10/26/2010
Yildirim I, Hanage WP, Lipsitch M, Shea KM, Stevenson A, Finkelstein J, Huang SS, Lee GM, Kleinman K, Pelton SI. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010 Dec 16; 29(2):283-8.
- Published on 4/1/2010
Hsu KK, Shea KM, Stevenson AE, Pelton SI. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J. 2010 Apr; 29(4):289-93.
- Published on 5/14/2008
Mahon BE, Shea KM, Dougherty NN, Loughlin AM. Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: a cross-sectional study. BMC Public Health. 2008; 8:160.
View 1 more publications:View full profile at BUMC
- Published on November 17, 2014